Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Non-Current Deffered Revenue (2021 - 2025)

Biote has reported Non-Current Deffered Revenue over the past 5 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $1.1 million for Q4 2025, down 29.36% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 29.36% YoY), and the annual figure for FY2025 was $1.1 million, down 29.36%.
  • Non-Current Deffered Revenue for Q4 2025 was $1.1 million at Biote, down from $1.2 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for BTMD hit a ceiling of $11.1 million in Q1 2021 and a floor of $802000.0 in Q4 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $1.4 million (2023), compared with a mean of $3.2 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 92.32% in 2022 and later soared 44.16% in 2024.
  • Biote's Non-Current Deffered Revenue stood at $802000.0 in 2021, then rose by 15.46% to $926000.0 in 2022, then skyrocketed by 42.76% to $1.3 million in 2023, then rose by 17.47% to $1.6 million in 2024, then decreased by 29.36% to $1.1 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $1.1 million (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.